Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled analysis by HER2 and ER status.
Chris Twelves
Consultant or Advisory Role - Eisai
Honoraria - Eisai
Other Remuneration - Eisai
Javier Cortes
Consultant or Advisory Role - Celgene; Novartis; Roche
Honoraria - Celgene; Eisai; Novartis; Roche
Linda T. Vahdat
Consultant or Advisory Role - Eisai
Honoraria - Bristol-Myers Squibb; Eisai; Genomic Health
Martin S. Olivo
Employment or Leadership Position - Eisai
Yi He
Employment or Leadership Position - Eisai
Peter Andrew Kaufman
Consultant or Advisory Role - Eisai
Honoraria - Eisai
Ahmad Awada
No relevant relationships to disclose